Navigation Links
Gentag, Inc. Engages US and UK Firms to Explore Strategic Options
Date:3/17/2009

LONDON and WASHINGTON, March 17 /PRNewswire/ -- Gentag, Inc. (Gentag) announced today that its Board of Directors has engaged VCG & Associates Inc. and Talisman Management Ltd. to assist the Company relating to the sale or license of all or parts of its IP portfolio. VCG & Associates Inc. will provide assistance relating to pharmaceutical and medical diagnostic uses on a global or specific geographic basis. Talisman Management Ltd. will evaluate all other opportunities. Gentag does not anticipate making another announcement in this regard to this matter unless its Board has approved a definitive transaction.

"Gentag has pioneered the concept of combining cell phones with MEMS, RFID and other sensors to create low cost ubiquitous cell phone-sensor networks. Cell phone-sensor networks will broadly impact healthcare, medical diagnostics, Homeland Security and other emerging markets such as 'smart' homes. Currently, the company and its partners are developing innovative low cost monitoring solutions for diabetes, prostate cancer, blood pressure and other common health conditions such as obesity that can be monitored directly by cellular telephones," stated Dr. John P. Peeters, President of Gentag. "With the global adoption of RFID cell phones by all major OEMs and the need to reduce medical costs worldwide our patented solution is creating immediate new market opportunities for the healthcare, IT, telecommunication and defense industries. We look forward to working with VCG & Associates Inc. and Talisman Management Ltd. to assist us in exploring our options and to maximize the full potential of our technology portfolio."

About Gentag, Inc. - Gentag, Inc. is a technology development company focusing on innovative, low-cost, wireless sensor network technologies based on cell phones. The company owns unique intellectual property relating to cell phone-sensor combinations and wireless sensor networks, including US patents 6,031,454, 7,109,859, 7,148,803, 7,461,972, 7,492,254 and other pending or approved US and international patents. The effective combination of cell phones with a disposable wireless sensor platform has led to a variety of diagnostic applications providing consumers, physicians, and various industries with instant access to vital information over established wireless networks, the Internet, and client-specific databases. The company is the recipient of the 2008 North American Technology Innovation Award from Frost & Sullivan.

About VCG & Associates Inc. - VCG & Associates, Inc. is an independent US strategic marketing and contract national account organization specializing in the commercialization, licensing and acquisition/disposition of pharmaceutical, biotech, and medical device products.

About Talisman Management, Ltd. - Talisman Management Ltd. is an advisory group based in London and its geographic focus is primarily on Europe and North America.


'/>"/>
SOURCE Gentag, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MMR Information Systems, Inc. Engages Houlihan Smith
2. Shire Engages Palio
3. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
4. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
5. Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite
6. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
7. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
8. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
9. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
10. Senetek Affirms Strong Financial Position
11. Online Systems Engineering Master's Program Attracts Engineers from Fortune 500 Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):